LSE - Delayed Quote GBp

Croda International Plc (50GP.L)

Compare
78.00
-0.50
(-0.64%)
As of March 19 at 12:44:55 PM GMT. Market Open.
Loading Chart for 50GP.L
  • Previous Close 78.50
  • Open 78.00
  • Bid 65.00 x --
  • Ask --
  • Day's Range 78.00 - 78.00
  • 52 Week Range 0.39 - 85.00
  • Volume 7,950
  • Avg. Volume 213
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.83
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 229.50
  • Earnings Date Feb 25, 2025
  • Forward Dividend & Yield 0.06 (7.56%)
  • Ex-Dividend Date Nov 28, 2024
  • 1y Target Est --

Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations. In addition, the company offers crop protection and seed enhancement related solutions. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.

www.croda.com

6,027

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 50GP.L

View More

Performance Overview: 50GP.L

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

50GP.L
9,297.59%
FTSE 100 (^FTSE)
5.45%

1-Year Return

50GP.L
10,534.38%
FTSE 100 (^FTSE)
2.32%

3-Year Return

50GP.L
9,249.95%
FTSE 100 (^FTSE)
2.33%

5-Year Return

50GP.L
10,232.48%
FTSE 100 (^FTSE)
35.47%

Compare To: 50GP.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 50GP.L

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.73%

  • Return on Assets (ttm)

    4.09%

  • Return on Equity (ttm)

    6.84%

  • Revenue (ttm)

    1.63B

  • Net Income Avi to Common (ttm)

    158.5M

  • Diluted EPS (ttm)

    229.50

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    166.8M

  • Total Debt/Equity (mrq)

    30.44%

  • Levered Free Cash Flow (ttm)

    122.56M

Research Analysis: 50GP.L

View More

Company Insights: 50GP.L

Research Reports: 50GP.L

View More